Jay S. Duker
About Jay S. Duker
Title and Current Roles
Jay S. Duker is the President & CEO and a Board Director at EyePoint Pharmaceuticals. He started his current role in July 2023. He joined EyePoint in 2020 and has held various key positions within the company including President and Chief Operating Officer, and Chief Strategic Scientific Officer. Additionally, he has served as a Board Director at EyePoint, initially from 2016 to 2020, and was re-appointed to the Board in July 2023.
Ophthalmology Career and Contributions
Jay S. Duker has devoted more than 30 years to the field of ophthalmology. He has focused on improving eyesight and preventing blindness. Duker was the Director of the New England Eye Center (NEEC) and the Professor and Chair of the Department of Ophthalmology at Tufts Medical Center and the Tufts University School of Medicine from 2001 to 2021. He remains active in clinical practice, treating patients with medical retinal disorders and intraocular tumors.
Research and Publications
Jay S. Duker is a prolific author with over 345 journal articles to his name. His research primarily centers on retinal imaging, retinal vascular diseases, and drug delivery to the posterior segment. His contributions to the ophthalmology field are widely recognized and respected.
Educational Background
Jay S. Duker received an A.B. from Harvard University and holds an M.D. from Jefferson Medical College of Thomas Jefferson University. His educational qualifications underpin his extensive career in ophthalmology and his leadership roles in various companies and medical institutions.
Entrepreneurial Ventures
Jay S. Duker is the founder of three successful start-up companies: SurgiSite Boston, the Boston Image Reading Center (BIRC), and Hemera Biosciences. His entrepreneurial efforts have significantly impacted the medical field, especially in ophthalmology.